Physician

John C Blankenship

According to 2025 Medicare claims, John Blankenship (NPI: 1730160177) practices urology in the Athens-Clarke County, GA market, with the plurality of this provider's patient population coming from Clarke, GA. This provider's primary affiliated billing organization is UROLOGY GROUP OF ATHENS, P.C. (NPI: 1366520165; TIN: 582170099) and primary practice location at 30606-6736.

Blankenship's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,558 traditional Medicare patients, billed 30,401 HCPCS/CPT codes, and received $909,485 in Medicare payments. The top billing code was 81007 (Urinalysis for bacteria). Part D data shows 7,081 prescription claims across 1,713 beneficiaries totaling $2,612,293 in drug costs, led by Xtandi (Enzalutamide). DME data shows 107 claims. Open Payments data shows 71 records totaling $2,070. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $306,622 to $909,485. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $225,139 to $2,612,293. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $680 to $539.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	870	10,457	$306,622
2016	820	10,465	$466,127
2017	877	7,945	$239,975
2018	917	8,076	$249,367
2019	898	7,267	$234,275
2020	1,245	22,367	$834,255
2021	1,212	32,793	$1,228,856
2022	1,461	26,619	$801,691
2023	1,373	17,978	$491,787
2024	1,558	30,401	$909,485

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	470	2,059	$225,139
2016	509	2,372	$414,547
2017	541	2,510	$295,818
2018	576	2,592	$548,147
2019	601	2,635	$513,369
2020	941	3,620	$1,358,060
2021	890	3,230	$1,864,274
2022	1,311	4,406	$2,226,140
2023	1,588	6,501	$2,346,443
2024	1,713	7,081	$2,612,293

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	71	$7,147
2016	N/R	130	$17,245
2017	11	122	$23,480
2018	N/R	143	$56,218
2019	N/R	134	$29,717
2020	23	160	$49,145
2021	14	129	$65,751
2022	22	135	$49,704
2023	N/R	131	$62,948
2024	N/R	107	$45,086

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
81007	Urinalysis for bacteria	1,255	1,965	$29
82010	Ketone bodies analysis, quantitative	1,259	1,975	$8
84311	Chemical analysis using spectrophotometry (light)	1,259	1,975	$8
82043	Urine microalbumin (protein) level	1,244	1,942	$6
82945	Glucose (sugar) level on body fluid	1,259	1,975	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xtandi	Enzalutamide	108	3,360	$1,562,297
Orgovyx	Relugolix	107	3,198	$288,626
Myrbetriq	Mirabegron	354	15,944	$243,604
Nubeqa	Darolutamide	12	360	$161,438
Gemtesa	Vibegron	87	3,724	$58,492

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	32	$32,923
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	26	$10,930
A4358	Urinary drainage bag, leg or abdomen, vinyl, with or without tube, with straps, each	N	N/R	15	$625
A4357	Bedside drainage bag, day or night, with or without anti-reflux device, with or without tube, each	N	N/R	22	$565
A4455	Adhesive remover or solvent (for tape, cement or other adhesive), per ounce	N	N/R	12	$43

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	71	$2,070	Axonics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for John C. Blankenship?

Tedicare shows public-source Medicare data for John C. Blankenship (NPI 1730160177), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does John C. Blankenship have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to John C. Blankenship?

John C. Blankenship is linked to UROLOGY GROUP OF ATHENS, P.C. (billing NPI 1366520165) in the available physician profile data.

Does John C. Blankenship have Open Payments data?

John C. Blankenship has 71 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.